Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
OwnerDavid A Steenblockinventor
Life of this patent
Estimating the term…
Abstract
A neurological disease is treated by administering to a patient a therapeutically effective amount of a composition including human umbilical cord stem cells. The composition may include growth factors mixed with the stem cells immediately prior to being administered. A specific pre and post transplantation protocol provides optimal methods for obtaining favorable clinical results.
Claims40
A method of treating a neurological disease comprising the step of administering to a patient a therapeutically effective amount of a composition including stem cells derived from an umbilical cord.
A method of treating cerebral palsy or traumatic brain injury comprising the step of administering to a patient a dose of at least 1 million umbilical cord stem cells of which at least substantially 85% of the cells are selected from the group consisting of CD133+ umbilical cord stem cells, CD44− umbilical cord stem cells, CD45− umbilical cord stem cells, CD34−/45+ umbilical cord stem cells, CD34−/45− umbilical cord stem cells, and mesenchymal umbilical cord stem cells.
A composition of matter comprising a mixture of human umbilical cord stem cells and growth factors mixed with the stem cells substantially immediately prior to administration of a single dose of the composition to a patient.
A composition of matter comprising a mixture of human umbilical cord stem cells and blood plasma.
Dependencies are inferred from the claim text.